Weight loss, which commonly occurs with tirzepatide therapy, can influence hormonal balance and thermoregulation, though evidence suggests that weight loss may actually improve vasomotor symptoms in some overweight postmenopausal women
Product Details Form: Lyophilized powder (for laboratory research) Amounts: 6 mg BPC-157 + 6 mg TB-500 per vial OR 10 mg BPC-157 + 10 mg TB-500 per vial Purity: 98% (HPLC tested) BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids) Molecular Formula: CHNO Molecular Weight: ~1419.5 g/mol TB-500 Sequence (Thymosin Beta-4 fragment 1723): Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Lys-Thr-Glu-Thr (43 amino acids) Molecular Formula: CHNOS Molecular Weight: ~4963 Da Intended Use: Laboratory research only DISCLAIMER: This product is strictly to be used for scientific research use only
Every protocol is tailored to your medical history, goals, and response
Those publications include fewer than 40 actual humans, there is no identified high-affinity receptor for BPC-157 in the human body, and no randomized trial has ever demonstrated any evidence that it works
Healing of duodenal ulcers is not impaired by indomethacin or rofecoxib, the selective COX-2 inhibitor, in rats
Although rare, allergic reactions may develop, particularly in those sensitive to components like vitamin C, magnesium, calcium, or B vitamins
